Evidence map›Paper›PMID 33994635›Full record

ArticleArchivos de bronconeumologia2020

Hydroxychloroquine and Potential Drug Interactions in Older Adults.

Verónica Velasco-González, Ana Fernández-Araque, Maria Sainz-Gil, Natalia Jimeno, Luis H Martín, Zoraida Verde

Abstract readCase Reports
In one paragraph

Article in Archivos de bronconeumologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Case Report:Frontiers in medicine · 2025
    Article
  2. Article
  3. Article
  4. Potential interactions between antineoplastic agents and medicines used to treat Covid-19.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Verónica Velasco-GonzálezDepartment of Nursery, University of Valladolid, Valladolid, Spain.
Ana Fernández-AraqueRecognized research group "Pharmacogenetics, Cancer Genetics, Genetic Polymorphisms and Pharmacoepidemiology", University of Valladolid, Valladolid, Spain.
Maria Sainz-GilRecognized research group "Pharmacogenetics, Cancer Genetics, Genetic Polymorphisms and Pharmacoepidemiology", University of Valladolid, Valladolid, Spain.
Natalia JimenoRecognized research group "Pharmacogenetics, Cancer Genetics, Genetic Polymorphisms and Pharmacoepidemiology", University of Valladolid, Valladolid, Spain.
Luis H MartínDepartment of Nursery, University of Valladolid, Valladolid, Spain.
Zoraida VerdeRecognized research group "Pharmacogenetics, Cancer Genetics, Genetic Polymorphisms and Pharmacoepidemiology", University of Valladolid, Valladolid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HydroxychloroquineAgedAntiviral AgentsDrug InteractionsHumansAntiviral AgentsHydroxychloroquine

Identifiers

PMID33994635
PMCPMC7358730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.